Description
Rysomep is listed in the ANVIS product catalogue. This page brings together its product information and original packaging image. Check the full name on the supplied pack before requesting further details.
Rysomep product details
Rysomep Injection is a sterile, lyophilized formulation containing Esomeprazole Sodium BP 40 mg, intended for intravenous (I.V.) administration. This proton pump inhibitor (PPI) provides rapid and sustained suppression of gastric acid secretion by blocking the hydrogen-potassium ATPase enzyme system in the gastric parietal cells.
Indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, gastric and duodenal ulcers, and Zollinger-Ellison syndrome, Rysomep is especially useful when oral therapy is not suitable. It is administered under medical supervision in hospital or clinical settings, offering prompt symptom relief and protecting the gastrointestinal mucosa during acute acid-related episodes.
Each carton contains one brown glass vial with a blue flip-off cap, preserving sterility and pharmaceutical integrity. Manufactured by ANVIS, the product adheres to international GMP standards, with clear labeling and instructions to support safe and effective use
Packaging and identification
First, match the product name, formulation and labelled strength to the item supplied. Also check the pack size and ingredient list on the complete label. Different presentations may have different directions. Therefore, do not use the pack quantity as a dose or treatment duration.
Documentation and enquiries
For current specifications or availability, contact ANVIS with the product name and a clear photo of the supplied label. Alternatively, browse the ANVIS product catalogue for related presentations. Ask a healthcare professional about suitability, interactions and directions. The MedlinePlus medicines and supplements directory provides general background; it does not replace the leaflet for this exact product.
